DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Results from a National Institute on Drug Abuse (NIDA)-funded study evaluating the efficacy and safety of naltrexone for extended-release injectable suspension ...
The U.S. Food & Drug Adminstration has issued a warning letter to Alkermes, Inc., the makers of Vivitrol, for failing to disclose the injectable drug's most serious risks in an advertisement. Vivitrol ...
An injectable medicine that helps people addicted to opioids get clean is gaining in popularity as an alternative to methadone, and Long Islanders who used it say it stopped their opioid cravings and ...
-- Retail Pharmacies, Including 900 Albertsons Locations, Added to the Provider Locator to Provide Injections of ARISTADA and VIVITROL; Additional Programs In Place to Deliver Support and Financial ...
Vivitrol is the injectible form of the generic drug called Naltrexone. It can cost between $1,100 and $1,600 for a one-month dose. Enrique Martinez was dripping water when he walked into Fifth Street ...
60.5 people in Cumberland County die from drug overdoses out of every 100,000 residents. Vivitrol was introduced in 2006. Patients only have to receive Vivitrol once a month via an injection in the ...
At the very moment that the Trump administration has thrown its weight behind a particular medication meant to deter opioid addiction, a new paper in a public-health journal is warning that too little ...
A print advertisement of Alkermes Plc's addiction treatment, Vivitrol, is false or misleading as it omits important risk information associated with its use, the Food and Drug Administration said in a ...
DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Results from a National Institute on Drug Abuse (NIDA)-funded study evaluating the efficacy and safety of naltrexone for extended-release injectable suspension ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback